NCT05587621View on ClinicalTrials.gov

Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
ST Elevation Myocardial InfarctionNon-ST Elevation Myocardial InfarctionLDL-cholesterol
Interventions
DRUG

statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran

dietary advice for low cholesterol food

Trial Locations (10)

07747

University Hospital Jena, Jena

Unknown

Universitätsmedizin Berlin, Berlin

Universitätsklinikum Dresden, Dresden

Universitätsklinikum Essen, Essen

Universitätsklinikum Frankfurt, Frankfurt

Universitätsklinikum Freiburg, Freiburg im Breisgau

Universitätsklinikum Halle, Halle

Universitätsklinikum des Saarlandes, Homburg

Universitätsklinikum Leipzig, Leipzig

Universitätsklinikum Regensburg, Regensburg

All Listed Sponsors
lead

Jena University Hospital

OTHER

NCT05587621 - Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target) | Biotech Hunter | Biotech Hunter